Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD

It is not known whether sputum elastase, metalloproteinase (MMP)-9 and tissue-inhibitor metalloproteinase (TIMP)-1 are related to structural changes of the airways, as assessed by high-resolution computed tomography (HRCT) scan. The relationships between these markers and the magnitude of structural changes of the airways in asthma and chronic obstructive pulmonary disease (COPD) were assessed. Induced sputum and HRCT scan were performed in 30 asthmatics (14 mild and 16 severe) and in 12 patients with COPD. A greater extent of HRCT scan abnormalities was found in COPD than in severe and mild asthmatics. HRCT scan abnormalities correlated with the degree of airway obstruction in COPD and in severe asthma. HRCT scan abnormalities also correlated with the levels of sputum elastase both in COPD and in severe asthma. HRCT scan abnormalities were associated with sputum MMP-9/TIMP-1 ratio in mild asthma, severe asthma and COPD. In conclusion, this study demonstrates that sputum elastase and the metalloproteinase-9/tissue-inhibitor metalloproteinase-1 ratio are associated with the magnitude of high-resolution computed tomography scan abnormalities of the airways in asthma and chronic obstructive pulmonary disease, and suggests that the levels of these markers reflect the extent of structural changes of the airways.

[1]  R. Peslin,et al.  Symbols, abbreviations and units. Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. , 1993, The European respiratory journal. Supplement.

[2]  J. Bousquet,et al.  Increased Levels of Elastase and α1-Antitrypsin in Sputum of Asthmatic Patients , 1998 .

[3]  L. Boulet,et al.  Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction. , 1995, American journal of respiratory and critical care medicine.

[4]  J. Foidart,et al.  Matrix metalloproteinases and TIMP‐1 production by peripheral blood granulocytes from COPD patients and asthmatics , 2001, Allergy.

[5]  P. Paré,et al.  Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. , 2000, American journal of respiratory and critical care medicine.

[6]  P Grenier,et al.  Cylindrical bronchiectasis: diagnostic findings on thin-section CT. , 1997, AJR. American journal of roentgenology.

[7]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[8]  G. Snider.  Chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology. , 1989, The American review of respiratory disease.

[9]  J. Bousquet,et al.  Computed tomography of the lungs in asthma: influence of disease severity and etiology. , 1996, American journal of respiratory and critical care medicine.

[10]  G G King,et al.  Evaluation of airways in obstructive pulmonary disease using high-resolution computed tomography. , 1999, American journal of respiratory and critical care medicine.

[11]  J. Bousquet,et al.  Glucocorticoid Receptor α and β in Glucocorticoid Dependent Asthma , 2000 .

[12]  G. O'Connor,et al.  The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.

[13]  G Gamsu,et al.  CT of a bronchial phantom. Factors affecting appearance and size measurements. , 1984, Investigative radiology.

[14]  P. Paré,et al.  Human airway narrowing measured using high resolution computed tomography. , 1996, American journal of respiratory and critical care medicine.

[15]  J. Austin,et al.  Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. , 1996, Radiology.

[16]  J. Bousquet,et al.  Bronchial elastic fibers in normal subjects and asthmatic patients. , 1996, American journal of respiratory and critical care medicine.

[17]  R. R. Wright.  Elastic tissue of normal and emphysematous lungs. A tridimensional histologic study. , 1961, The American journal of pathology.

[18]  J. Bousquet,et al.  Tissue inhibitor of metalloproteinase-1 levels in bronchoalveolar lavage fluid from asthmatic subjects. , 1999, American journal of respiratory and critical care medicine.

[19]  J Dosman,et al.  The relations between structural changes in small airways and pulmonary-function tests. , 1978, The New England journal of medicine.

[20]  J. Remy,et al.  Comparison of vertical and oblique CT in evaluation of bronchial tree. , 1988, Journal of computer assisted tomography.

[21]  K. Kubo,et al.  The relations between expiratory chest CT using helical CT and pulmonary function tests in emphysema. , 1997, American journal of respiratory and critical care medicine.

[22]  A. Kugler.  Matrix metalloproteinases and their inhibitors. , 1999, Anticancer research.

[23]  C. W. Kim,et al.  High-resolution computed tomography in patients with bronchial asthma: correlation with clinical features, pulmonary functions and bronchial hyperresponsiveness. , 1997, Journal of investigational allergology & clinical immunology.

[24]  K. J. Macleod,et al.  High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity , 2002, Thorax.

[25]  K. P. Van de Woestijne,et al.  The senile lung. Comparison with normal and emphysematous lungs. 1. Structural aspects. , 1992, Chest.

[26]  J. Bousquet,et al.  Effect of age and asthma duration upon elastase and α1-antitrypsin levels in adult asthmatics , 2003, European Respiratory Journal.

[27]  N. Zamel,et al.  Unsuspected pseudophysiologic emphysema in chronic persistent asthma. , 2000, American journal of respiratory and critical care medicine.

[28]  R. Stockley.  The role of proteinases in the pathogenesis of chronic bronchitis. , 1994, American journal of respiratory and critical care medicine.

[29]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.

[30]  H Itoh,et al.  Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices. , 2000, American journal of respiratory and critical care medicine.

[31]  M S Frank,et al.  CT of the lung in patients with pulmonary emphysema: diagnosis, quantification, and correlation with pathologic and physiologic findings. , 1994, AJR. American journal of roentgenology.

[32]  J. Bousquet,et al.  Chest radiography and high resolution computed tomography of the lungs in asthma. , 1992, The American review of respiratory disease.

[33]  A Janoff,et al.  Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. , 1985, The American review of respiratory disease.

[34]  D M Hansell,et al.  CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. , 1995, AJR. American journal of roentgenology.

[35]  P. Saldiva,et al.  Elastosis and fragmentation of fibers of the elastic system in fatal asthma. , 1999, American journal of respiratory and critical care medicine.

[36]  P. Grenier,et al.  Bronchiectasis: comparative assessment with thin-section CT and helical CT. , 1996, Radiology.

[37]  R B Douglas,et al.  The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. , 1980, The American review of respiratory disease.

[38]  S. Neumann,et al.  “PMN-Elastase Assay”: Enzyme Immunoassay for Human Polymorphonuclear Elastase Complexed with α1-Proteinase Inhibitor , 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[39]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[40]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[41]  K. P. Van de Woestijne,et al.  The senile lung. Comparison with normal and emphysematous lungs. 2. Functional aspects. , 1992, Chest.

[42]  J. Roca,et al.  Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[43]  L Battolla,et al.  Relationship between extent of pulmonary emphysema by high-resolution computed tomography and lung elastic recoil in patients with chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[44]  D. Revel,et al.  Thin-section CT detection of emphysema associated with bronchiectasis and correlation with pulmonary function tests. , 1996, Chest.

[45]  J. Bousquet,et al.  Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. , 2000, American journal of respiratory and critical care medicine.

[46]  J Bousquet,et al.  Measurement of the internal size of bronchi using high resolution computed tomography (HRCT) , 1994, The European respiratory journal.

[47]  L. Matrisian,et al.  Matrix degrading metalloproteinases , 2005, Journal of Neuro-Oncology.

[48]  G. Guyatt,et al.  Development and validation of the Mini Asthma Quality of Life Questionnaire. , 1999, The European respiratory journal.

[49]  J. Roca,et al.  Standardization of the measurement of transfer factor (diffusing capacity) , 1993, European Respiratory Journal.

[50]  J. Bousquet,et al.  Tissue remodeling as a feature of persistent asthma. , 2000, The Journal of allergy and clinical immunology.

[51]  Heterogeneity of airways obstruction in asthmatic patients using high-resolution computed tomography. , 1995, Chest.

[52]  P. Paré,et al.  Quantitative assessment of airway remodeling using high-resolution CT. , 2002, Chest.

[53]  M. Belvisi,et al.  The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs? , 2003, Inflammation Research.

[54]  S. Rennard,et al.  Evaluation of elastase and antielastase balance in patients with chronic bronchitis and pulmonary emphysema. , 1990, The American review of respiratory disease.

[55]  R. Peslin,et al.  Symbols, abbreviations and units , 1993, European Respiratory Journal.

[56]  J. Bousquet,et al.  Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. , 1998, American journal of respiratory and critical care medicine.

[57]  P. O'Byrne,et al.  Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. , 1992, The American review of respiratory disease.

[58]  G Gamsu,et al.  High-resolution CT of the lungs: an optimal approach. , 1987, Radiology.

[59]  P. Paré,et al.  The diagnosis of emphysema. A computed tomographic-pathologic correlation. , 1986, The American review of respiratory disease.

[60]  J Bousquet,et al.  Asthma. From bronchoconstriction to airways inflammation and remodeling. , 2000, American journal of respiratory and critical care medicine.